Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRR | Q9GZT4 | 2/20 | 0.62 |
| ▸ | PPARG | P37231 | 17/20 | 0.54 |
| ▸ | PPARA | Q07869 | 15/20 | 0.54 |
| ▸ | ACE | P12821 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9427716 | 0.86 | SRR (0.50) | SRRPPARGPPARA | |
| SCHEMBL30312733 | 0.84 | SRR (0.49) | SRRPPARGPPARA | |
| SCHEMBL3781159 | 0.83 | SRR (0.65) | SRRPPARGPPARA | |
| SCHEMBL6429518 | 0.83 | SRR (0.65) | SRRPPARGPPARA | |
| SCHEMBL10798806 | 0.83 | SRR (0.65) | SRRPPARGPPARA | |
| SCHEMBL4993002 | 0.81 | PPARA (0.69) | SRRPPARGPPARA | |
| SCHEMBL1670312 | 0.81 | PPARA (0.69) | SRRPPARGPPARA | |
| SCHEMBL1932308 | 0.80 | SRR (0.61) | SRRPPARGPPARAACE | |
| SCHEMBL5038982 | 0.79 | NPC1 (0.50) | SRR | |
| SCHEMBL4298981 | 0.79 | SRR (0.59) | SRRPPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12343323-B2 | Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof | SANTOLECAN PHARMACEUTICALS LLC (US) | 2025-07-01 | — | — | US | disclosed |
| US-20210228530-A1 | TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF | SANTOLECAN PHARMACEUTICALS LLC | 2021-07-29 | — | — | US | disclosed |
| EP-3812376-A1 | PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | Santolecan Pharmaceuticals LLC (US) | 2021-04-28 | — | — | EP | disclosed |
| WO-2019242691-A1 | PACLITAXEL-LIPID-POLYSACCHARIDE DUAL-TYPE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF | 圣多利康制药责任有限公司 | 2019-12-26 | — | — | WO | disclosed |
| CN-103641925-B | Water solublity polysaccharide and the covalency polyacetylene compound of bearing taxanes, its preparation method and medical usage | 王晖 | 2016-08-17 | — | — | CN | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12343323-B2 | Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof | DDOST, UGT2B17, UGT1A7 | SRR 3052/4885PPARG 2227/4885PPARA 966/4885 |
| US-20210228530-A1 | TAXANE-LIPID-POLYSACCHARIDE DUAL CONJUGATES, PREPARATION METHODS THEREOF AND USES THEREOF | DDOST, UGT2B17, UGT1A7 | SRR 3052/4885PPARG 2227/4885PPARA 966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.